1h Free Analyst Time
Advancements in sleep medicine and addiction treatment have elevated sodium oxybate to a cornerstone therapy, particularly for narcolepsy patients contending with cataplexy and excessive daytime sleepiness, as well as individuals undergoing alcohol dependence interventions. This compound, known for its central nervous system depressant properties, has demonstrated robust efficacy in managing these conditions, driving a surge in clinical adoption. The dual-purpose nature of sodium oxybate-addressing neurological sleep disruptions and supporting detoxification-underscores its strategic importance in modern pharmacotherapy. Moreover, as healthcare stakeholders intensify efforts to enhance patient outcomes through tailored regimens, understanding the evolving market dynamics for both brand and generic formulations becomes essential.Speak directly to the analyst to clarify any post sales queries you may have.
Since its initial introduction, sodium oxybate has benefited from successive regulatory approvals and formulation refinements that have expanded its clinical scope. Rising prevalence of narcolepsy and alcohol use disorders, coupled with greater diagnostic awareness and telehealth-enabled patient engagement, have created a favorable backdrop for growth. Tightening regulatory standards, shifting payer policies, and expanding clinical guidelines further influence adoption patterns, making a comprehensive overview indispensable for decision makers. As we navigate a complex environment shaped by patent expirations, emerging chemical processes, and global supply chain pressures, stakeholders require a clear, authoritative synthesis of current trends and future prospects.
Transformative Shifts Reshaping the Sodium Oxybate Domain
Recent years have witnessed several transformative shifts across the sodium oxybate market, driven by regulatory approvals of novel formulations, heightened generic competition, and accelerated adoption of patient-centric delivery mechanisms. The introduction of extended-release generics has not only expanded treatment options but also intensified pricing competition, compelling innovators to differentiate through formulation improvements and value-added services. Moreover, regulatory bodies in major markets have updated guidelines to streamline approval pathways for generics, thereby amplifying the pace of market entry for new players. Concurrently, digital health integration has emerged as a pivotal factor, with telemedicine platforms enabling remote titration and adherence monitoring, ultimately improving patient engagement and outcomes.Furthermore, the shift toward personalized medicine has prompted R&D investments aimed at optimizing dosage regimens based on patient demographics and comorbidities, leading to more tailored therapeutic strategies. Supply chain resilience has also become paramount, as manufacturers reevaluate sourcing strategies amid global disruptions, investing in dual sourcing and onshoring APIs to mitigate risk. Overall, these shifts are catalyzing a more competitive, innovation-driven landscape, compelling stakeholders to adapt swiftly to maintain market relevance.
Cumulative Impact of United States Tariffs 2025 on Market Dynamics
Implementation of United States tariffs on pharmaceutical inputs and finished goods in 2025 has introduced notable complexities into the sodium oxybate supply chain, affecting cost structures and strategic planning. Tariffs targeting key active pharmaceutical ingredients have elevated raw material expenses, leading to upward pressure on manufacturing costs that are often absorbed partially by manufacturers and partially passed to payers. In addition, levies on imported packaging materials have disrupted contract manufacturing timelines, as companies scramble to identify alternative domestic suppliers capable of meeting stringent quality standards.Consequently, vertical integration strategies have gained traction, with several producers investing in internal API production to offset tariff-related cost escalations. However, these initiatives require significant capital outlay and extended validation periods, introducing execution risks. Meanwhile, payers and pharmacy benefit managers are renegotiating contracts to mitigate budgetary impacts, which is amplifying downward pricing pressure on generics. Overall, the 2025 tariffs have reinforced the importance of agile sourcing, strategic partnerships, and cost-containment measures, reshaping competitive benchmarks across the value chain.
Key Segmentation Insights Across Product, Application, Demographics, Dosage, Distribution, End Users, and Administration
In dissecting the sodium oxybate market, granular segmentation reveals nuanced demand patterns across multiple dimensions. When considering product type, stakeholders evaluate brand sodium oxybate, which encompasses liquid formulations prized for dosing flexibility and tablet formulations optimized for patient compliance, alongside generic counterparts available as extended-release designs that offer sustained therapeutic levels and non-modified formulations that align closely with originator specifications. Application-driven analysis uncovers distinct trajectories in alcohol dependence cases, where detoxification support protocols and withdrawal symptom alleviation regimens demand consistent dosing accuracy, and narcolepsy treatment pathways, in which cataplexy relief and excessive daytime sleepiness management protocols benefit from rapid onset and customizable titration. Patient demographics further stratify the market: age group distinctions among adults, children, and elderly cohorts inform safety and efficacy considerations; comorbidity profiles, especially patients with depressive disorders and those with psychiatric disorders, necessitate tailored risk-benefit assessments; and gender-specific responses in female and male populations drive targeted adherence strategies. The dosage form dimension differentiates multiple-dose options, such as capsules and powder sachets designed for home administration, from single-dose formats, including premeasured liquids and tablets that simplify on-the-go dosing. Distribution channel analysis highlights the roles of hospital pharmacies-spanning inpatient dispensing and outpatient services-online pharmacies operated by e-commerce giants and specialized health portals, and retail chains alongside independent outlets that cater to diverse patient access preferences. Finally, end users range from healthcare institutions, which integrate clinics, hospitals, and wellness centers focused on therapeutic protocols, to research organizations engaged in clinical trials and laboratory investigations that underpin next-generation formulations. Route of administration remains singularly oral, with intact tablets favored for ease of use and solution administration valued for flexible titration.Key Regional Insights Highlighting Differentiated Market Drivers and Dynamics
The Americas dominate the global landscape, propelled by robust reimbursement frameworks, high disease awareness, and established distribution networks that facilitate rapid adoption of innovative formulations. In the United States, integrated care models and telehealth expansion drive increased diagnosis rates for narcolepsy and alcohol dependence, creating fertile ground for sodium oxybate therapies. Meanwhile, Canada’s supportive regulatory environment and provincial formulary updates foster incremental volume growth, particularly within public payor plans.Europe, Middle East & Africa exhibit heterogeneity in market maturity and access paradigms. Western European nations benefit from comprehensive health technology assessments and favorable labeling extensions, whereas emerging markets in Eastern Europe, the Middle East, and Africa face challenges related to infrastructure constraints and limited supply chain reach. Nevertheless, cross-border regulatory harmonization initiatives and growing public-private partnerships are gradually improving product availability and fostering competitive pricing for both brand and generic options.
Asia-Pacific represents a high-growth frontier, driven by rising healthcare expenditure, expanding patient education programs, and increased local production capabilities. Key markets such as Japan and Australia maintain stringent approval standards akin to Western benchmarks, ensuring high-quality uptake, while emerging economies in Southeast Asia and India deliver volume-driven growth propelled by generic manufacturing hubs and evolving reimbursement schemes. Together, these regional dynamics underscore the necessity for tailored market entry strategies and adaptive pricing models.
Key Companies Insights Illuminating Competitive Strategies and Portfolio Priorities
Leading innovators and generics manufacturers are executing diverse strategies to capture share in the sodium oxybate arena. ACADIA Pharmaceuticals Inc. focuses on extending label indications and enhancing patient support services, while Alkermes plc leverages its formulation expertise to improve extended-release profiles. Amneal Pharmaceuticals, Inc. and Dr. Reddy’s Laboratories emphasize scale efficiencies and price competitiveness through advanced manufacturing facilities and strategic API partnerships. Hikma Pharmaceuticals invests in geographic expansion and regulatory submissions to penetrate underserved markets, whereas Jazz Pharmaceuticals capitalizes on brand heritage and specialty sales forces to sustain market leadership in narcolepsy.Lupin Pharmaceuticals, Inc. and Mylan N.V. (Viatris) are notable for their aggressive generic launches and patient affordability programs, seeking to democratize access without compromising quality. Sun Pharmaceutical Industries Ltd. combines cost-effective production with incremental formulation innovations, and Teva Pharmaceutical Industries Ltd. integrates digital adherence tools into its therapy offerings to drive long-term engagement. Collectively, these companies underscore a competitive environment where pipeline diversification, channel optimization, and differentiated value propositions are critical to securing sustainable growth.
Actionable Recommendations for Industry Leaders to Navigate Emerging Challenges
To remain competitive in this dynamic landscape, companies should prioritize vertical integration by establishing in-house API capabilities and diversifying raw material sources to mitigate tariff-related volatility. In addition, investing in extended-release and patient-tailored formulations will differentiate portfolios and address evolving adherence needs. Engaging with digital health partners to embed telemonitoring and adherence tracking into therapy regimens can enhance patient outcomes and generate real-world evidence that supports payer negotiations. Furthermore, forging collaborative ventures with contract research organizations and academic centers will accelerate post-market studies assessing safety across comorbidity profiles and demographic segments. Finally, adopting region-specific market penetration strategies-aligning pricing structures with local reimbursement policies and leveraging public-private initiatives-will enable more efficient access to underserved populations.Conclusion Emphasizing Strategic Imperatives and Market Outlook
Overall, the sodium oxybate oral medications market is undergoing rapid evolution driven by formulation innovations, regulatory shifts, and supply chain realignments. Tariff pressures have catalyzed a reevaluation of sourcing strategies, while segmentation insights highlight the need for targeted solutions that cater to diverse patient needs across age, comorbidity, and administration preferences. Regional nuances further demand adaptive market entry and pricing models, and competitive dynamics emphasize the importance of differentiated pipelines and digital integrations. By synthesizing these insights and executing on actionable recommendations, stakeholders can navigate complexity, optimize portfolio performance, and ultimately deliver improved patient outcomes.Market Segmentation & Coverage
This research report categorizes the Sodium Oxybate Oral Medications Market to forecast the revenues and analyze trends in each of the following sub-segmentations:
- Brand Sodium Oxybate
- Liquid Formulations
- Tablet Formulations
- Generic Sodium Oxybate
- Extended-Release
- Non-Modified
- Alcohol Dependence Cases
- Detoxification Support
- Withdrawal Symptom Alleviation
- Narcolepsy Treatment
- Cataplexy Relief
- Excessive Daytime Sleepiness Management
- Age Group
- Adults
- Children
- Elderly
- Comorbidity
- Patients With Depressive Disorders
- Patients With Psychiatric Disorders
- Gender
- Female
- Male
- Multiple-Dose Formulations
- Capsules
- Powder Sachets
- Single-Dose Formulations
- Liquid
- Tablets
- Hospital Pharmacies
- Inpatient Dispensing
- Outpatient Pharmacy Services
- Online Pharmacies
- E-Commerce Giants
- Specialized Health Portals
- Retail Pharmacies
- Chain Pharmacies
- Independent Pharmacies
- Healthcare Institutions
- Clinics
- Hospitals
- Wellness Centers
- Research Organizations
- Clinical Trials
- Pharmaceutical Laboratories
- Oral
- Intact Tablets
- Solution Administration
This research report categorizes the Sodium Oxybate Oral Medications Market to forecast the revenues and analyze trends in each of the following sub-regions:
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
This research report categorizes the Sodium Oxybate Oral Medications Market to delves into recent significant developments and analyze trends in each of the following companies:
- ACADIA Pharmaceuticals Inc.
- Alkermes plc
- Amneal Pharmaceuticals, Inc.
- Dr. Reddy's Laboratories
- Hikma Pharmaceuticals
- Jazz Pharmaceuticals
- Lupin Pharmaceuticals, Inc.
- Mylan N.V. (Viatris)
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sodium Oxybate Oral Medications Market, by Product Type
8.1. Introduction
8.2. Brand Sodium Oxybate
8.2.1. Liquid Formulations
8.2.2. Tablet Formulations
8.3. Generic Sodium Oxybate
8.3.1. Extended-Release
8.3.2. Non-Modified
9. Sodium Oxybate Oral Medications Market, by Application
9.1. Introduction
9.2. Alcohol Dependence Cases
9.2.1. Detoxification Support
9.2.2. Withdrawal Symptom Alleviation
9.3. Narcolepsy Treatment
9.3.1. Cataplexy Relief
9.3.2. Excessive Daytime Sleepiness Management
10. Sodium Oxybate Oral Medications Market, by Patient Demographics
10.1. Introduction
10.2. Age Group
10.2.1. Adults
10.2.2. Children
10.2.3. Elderly
10.3. Comorbidity
10.3.1. Patients With Depressive Disorders
10.3.2. Patients With Psychiatric Disorders
10.4. Gender
10.4.1. Female
10.4.2. Male
11. Sodium Oxybate Oral Medications Market, by Dosage Form
11.1. Introduction
11.2. Multiple-Dose Formulations
11.2.1. Capsules
11.2.2. Powder Sachets
11.3. Single-Dose Formulations
11.3.1. Liquid
11.3.2. Tablets
12. Sodium Oxybate Oral Medications Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.2.1. Inpatient Dispensing
12.2.2. Outpatient Pharmacy Services
12.3. Online Pharmacies
12.3.1. E-Commerce Giants
12.3.2. Specialized Health Portals
12.4. Retail Pharmacies
12.4.1. Chain Pharmacies
12.4.2. Independent Pharmacies
13. Sodium Oxybate Oral Medications Market, by End User
13.1. Introduction
13.2. Healthcare Institutions
13.2.1. Clinics
13.2.2. Hospitals
13.2.3. Wellness Centers
13.3. Research Organizations
13.3.1. Clinical Trials
13.3.2. Pharmaceutical Laboratories
14. Sodium Oxybate Oral Medications Market, by Route of Administration
14.1. Introduction
14.2. Oral
14.2.1. Intact Tablets
14.2.2. Solution Administration
15. Americas Sodium Oxybate Oral Medications Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Sodium Oxybate Oral Medications Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Sodium Oxybate Oral Medications Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. ACADIA Pharmaceuticals Inc.
18.3.2. Alkermes plc
18.3.3. Amneal Pharmaceuticals, Inc.
18.3.4. Dr. Reddy's Laboratories
18.3.5. Hikma Pharmaceuticals
18.3.6. Jazz Pharmaceuticals
18.3.7. Lupin Pharmaceuticals, Inc.
18.3.8. Mylan N.V. (Viatris)
18.3.9. Sun Pharmaceutical Industries Ltd.
18.3.10. Teva Pharmaceutical Industries Ltd.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. SODIUM OXYBATE ORAL MEDICATIONS MARKET MULTI-CURRENCY
FIGURE 2. SODIUM OXYBATE ORAL MEDICATIONS MARKET MULTI-LANGUAGE
FIGURE 3. SODIUM OXYBATE ORAL MEDICATIONS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 20. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. SODIUM OXYBATE ORAL MEDICATIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. SODIUM OXYBATE ORAL MEDICATIONS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SODIUM OXYBATE ORAL MEDICATIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY BRAND SODIUM OXYBATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY TABLET FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY BRAND SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENERIC SODIUM OXYBATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY EXTENDED-RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NON-MODIFIED, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENERIC SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ALCOHOL DEPENDENCE CASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DETOXIFICATION SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY WITHDRAWAL SYMPTOM ALLEVIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ALCOHOL DEPENDENCE CASES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY CATAPLEXY RELIEF, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY EXCESSIVE DAYTIME SLEEPINESS MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY TREATMENT, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY AGE GROUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COMORBIDITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENTS WITH DEPRESSIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENTS WITH PSYCHIATRIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COMORBIDITY, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTIPLE-DOSE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY POWDER SACHETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTIPLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE-DOSE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INPATIENT DISPENSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OUTPATIENT PHARMACY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY E-COMMERCE GIANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SPECIALIZED HEALTH PORTALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY WELLNESS CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PHARMACEUTICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INTACT TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SOLUTION ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY BRAND SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENERIC SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ALCOHOL DEPENDENCE CASES, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COMORBIDITY, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTIPLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY BRAND SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENERIC SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ALCOHOL DEPENDENCE CASES, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY TREATMENT, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COMORBIDITY, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTIPLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY BRAND SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENERIC SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ALCOHOL DEPENDENCE CASES, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY TREATMENT, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COMORBIDITY, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTIPLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 142. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY BRAND SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 144. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENERIC SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 145. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ALCOHOL DEPENDENCE CASES, 2018-2030 (USD MILLION)
TABLE 147. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY TREATMENT, 2018-2030 (USD MILLION)
TABLE 148. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 149. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 150. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COMORBIDITY, 2018-2030 (USD MILLION)
TABLE 151. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 152. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 153. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTIPLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 154. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 155. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 157. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 158. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 159. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 161. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 162. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 163. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 164. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY BRAND SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 166. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENERIC SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 167. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ALCOHOL DEPENDENCE CASES, 2018-2030 (USD MILLION)
TABLE 169. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY TREATMENT, 2018-2030 (USD MILLION)
TABLE 170. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 171. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 172. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COMORBIDITY, 2018-2030 (USD MILLION)
TABLE 173. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 174. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 175. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTIPLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 176. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 177. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 179. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 180. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 181. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 183. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 184. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY BRAND SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENERIC SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ALCOHOL DEPENDENCE CASES, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY TREATMENT, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COMORBIDITY, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 197. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTIPLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY BRAND SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENERIC SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ALCOHOL DEPENDENCE CASES, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY TREATMENT, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 216. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COMORBIDITY, 2018-2030 (USD MILLION)
TABLE 218. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTIPLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY BRAND SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENERIC SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ALCOHOL DEPENDENCE CASES, 2018-2030 (USD MILLION)
TABLE 237. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY TREATMENT, 2018-2030 (USD MILLION)
TABLE 238. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 239. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 240. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COMORBIDITY, 2018-2030 (USD MILLION)
TABLE 241. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 242. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 243. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTIPLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 244. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 245. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 247. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 248. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 249. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 251. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 252. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 253. AUSTRALIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 254. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY BRAND SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 256. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENERIC SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 257. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ALCOHOL DEPENDENCE CASES, 2018-2030 (USD MILLION)
TABLE 259. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY TREATMENT, 2018-2030 (USD MILLION)
TABLE 260. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 261. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 262. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COMORBIDITY, 2018-2030 (USD MILLION)
TABLE 263. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 264. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 265. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTIPLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 266. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 267. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 269. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 270. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 271. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 273. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 274. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 275. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 276. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY BRAND SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 278. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENERIC SODIUM OXYBATE, 2018-2030 (USD MILLION)
TABLE 279. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ALCOHOL DEPENDENCE CASES, 2018-2030 (USD MILLION)
TABLE 281. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY TREATMENT, 2018-2030 (USD MILLION)
TABLE 282. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 283. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 284. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COMORBIDITY, 2018-2030 (USD MILLION)
TABLE 285. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 286. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 287. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTIPLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 288. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE-DOSE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 289. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 291. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 292. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 293. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 295. INDIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RESEARCH OR
Companies Mentioned
- ACADIA Pharmaceuticals Inc.
- Alkermes plc
- Amneal Pharmaceuticals, Inc.
- Dr. Reddy's Laboratories
- Hikma Pharmaceuticals
- Jazz Pharmaceuticals
- Lupin Pharmaceuticals, Inc.
- Mylan N.V. (Viatris)
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
Methodology
LOADING...
